Literature DB >> 1320638

Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder.

N Wodarz1, R Rupprecht, J Kornhuber, B Schmitz, K Wild, P Riederer.   

Abstract

This follow-up study investigated lymphocyte blastogenesis induced by concanavalin A, phytohemagglutinin A, and pokeweed mitogen and their sensitivity to in vitro dexamethasone administration in 12 patients clinically recovered from severe major depression. Although cortisol-levels at 4.00 p.m. decreased significantly after clinical remission, mitogen-driven lymphocyte proliferative responses were unchanged when assessed intra-individually. No impairment of in vitro glucocorticoid-sensitivity of lectin-induced lymphocyte blastogenesis could be observed in clinically recovered patients. The inhibitory potency of in vitro dexamethasone was found to be inversely correlated with in vivo adrenal cortical hormone levels. There were no correlations with age, weight, sex, antidepressant medication, severity or duration of depression. No differences from age- and sex-matched healthy individuals were found. These results indicate that reduced glucocorticoid receptor sensitivity occurs only during the acute depressive illness.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320638     DOI: 10.1016/0165-0327(92)90090-s

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

1.  Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients.

Authors:  Andreas Menke; Janine Arloth; Benno Pütz; Peter Weber; Torsten Klengel; Divya Mehta; Mariya Gonik; Monika Rex-Haffner; Jennifer Rubel; Manfred Uhr; Susanne Lucae; Jan M Deussing; Bertram Müller-Myhsok; Florian Holsboer; Elisabeth B Binder
Journal:  Neuropsychopharmacology       Date:  2012-01-11       Impact factor: 7.853

2.  Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters.

Authors:  C M Pariante; A Makoff; S Lovestone; S Feroli; A Heyden; A H Miller; R W Kerwin
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

3.  Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal.

Authors:  Alexandre Surget; Yingjie Wang; Samuel Leman; Yadira Ibarguen-Vargas; Nicole Edgar; Guy Griebel; Catherine Belzung; Etienne Sibille
Journal:  Neuropsychopharmacology       Date:  2008-06-04       Impact factor: 7.853

4.  Effects of glucocorticoids on 5-HT1A presynaptic function in the mouse.

Authors:  A H Young; G M Goodwin; H Dick; G Fink
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

Review 5.  Psychosocial determinants of recovery in depression.

Authors:  Giovanni A Fava; Dalila Visani
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.